Skip to main content
. 2013 May 16;8(5):e63388. doi: 10.1371/journal.pone.0063388

Figure 1. MIYAIRI 588 prevents progression of CDAA diet-induced liver steatosis to tumorigenesis.

Figure 1

Each group was investigated at 8, 16, and 50 weeks after completion of the diet regimen. MIYAIRI 588 was administered after CDAA diet feeding for 2 weeks. To confirm that the feeding of the CDAA diet caused the liver steatosis, the groups administered CSAA and CDAA were examined at 2 weeks after the commencement of this experiment. (A) Macroscopic histomorphology and (B) hematoxylin and eosin staining for microscopic histopathology were performed at the indicated time periods. Data are representative of 6 individual liver sections. Original magnification, ×25.